Global Competitive ELISA Market research

Competitive ELISA Comprehensive Study by Type (ELISA Sets, ELISA Kits), Application (Vaccine Development, Immunology, Diagnostics, Toxicology, Drug Development and Pharmaceutical Industry, Transplantation, Other), ELISA (Direct ELISA, Sandwich ELISA, Competitive ELISA, Reverse ELISA) Players and Region - Global Market Outlook to 2030

Competitive ELISA Market by XX Submarkets | Forecast Years 2024-2030  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Market Snapshot:
Competitive ELISA is a type of ELISA that relies on the completion between analyte antigen and labeled antigen for a limited quantum of specificanti body.Enzyme Linked Immunosorbent Assay( ELISA) is immunoassay used to identify proteins, peptides, antibodies, and hormones. ELISA assay has operation in biotechnology drug, as a individual tool, which detects color change to identify a target substance and measures its attention in the test sample. The common individual operations of ELISA are mortal Immunodeficiency Contagion( HIV) infection, gestation tests, and dimension of cytokines, answerable proteins, and others. colorful antigen- antibody combinations are used in the immunoassay that include an enzyme- labeled antigen or antibody and enzyme exertion is measured.

Highlights from Competitive ELISA Market Study
AttributesDetails
Study Period2018-2030
Base Year2023
Largest MarketNorth America
UnitValue (USD Million)


The key Players profiled in the report are Bio-Rad Laboratories (United States), Fisher Scientific (United States), Cell Biolabs, Inc. (United States), Enzo Life Sciences, Inc. (United States), Sino Biological Inc. (United States), BioVision, Inc. (United States), Invitrogen (United States), Hycult Biotech (Netherlands), Biomerieux (France) and ALPCO (United States). Additionally, other players that are part of this comprehensive study are BioLegend, Inc. (United States), ZEUS Scientific, Inc. (United States), Shenzhen YHLO Biotech Co., Ltd. (China) and Abnova (China).

Geographic Breakdown and Segment Analysis
The Global Competitive ELISA market presents a comprehensive analysis of the Competitive ELISA market by product type (ELISA Sets and ELISA Kits), by end-user/application (Vaccine Development, Immunology, Diagnostics, Toxicology, Drug Development and Pharmaceutical Industry, Transplantation and Other), and by geography (North America, South America, Europe, Asia-Pacific and MEA) along with country level break-up. This section of our report presents a realistic picture of the Global Competitive ELISA industry. Investors and Players can easily understand the inherent opportunities and challenges for their products in geographical region of interest. For instance, while the North America holds majority of market share of the Competitive ELISA market

Analyst at AMA have segmented the market study of Global Competitive ELISA market by Type, Application and Region.

Influencing Trend:
Emergence of Cost Effective Technologies and Laboratory Automation

Market Growth Drivers:
Rising Prevalence of Infectious Disease Such As HIV and Increased Awareness Regarding Diagnosis of Cancer and Autoimmune Diseases

Challenges:
Lack of Awareness in Developing Countries

Restraints:
Substitution by New Technologies

Opportunities:
Increasing the Need for Accurate and Early Disease Diagnosis and Rising Geriatric Population

Market Developments Activities:
In 2020, As part of this collaborative effort, Cipla would be responsible for the marketing and distribution of the SARS CoV-2-IgG antibody detection ELISA that will be manufactured by KARWA Ltd. ICMR has provided the requisite technological know-how and process for developing the test kits to the approved manufacturers.
In 2020, Cipla Limited, a pharmaceutical company had announced the commercialization of antibody detection kits for COVID-19 in India. In partnership with KARWA Ltd. a manufacturing and distributor company under the technology transfer from the Indian Council of Medical Research (ICMR).





Key Target Audience
Competitive ELISA Manufacturers, Raw Material Suppliers/ Buyers, Distributors, Research Professionals, Government Body & Associations and End-user

Report Objectives / Segmentation Covered

By Type
  • ELISA Sets
  • ELISA Kits
By Application
  • Vaccine Development
  • Immunology
  • Diagnostics
  • Toxicology
  • Drug Development and Pharmaceutical Industry
  • Transplantation
  • Other
By ELISA
  • Direct ELISA
  • Sandwich ELISA
  • Competitive ELISA
  • Reverse ELISA

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Prevalence of Infectious Disease Such As HIV
      • 3.2.2. Increased Awareness Regarding Diagnosis of Cancer and Autoimmune Diseases
    • 3.3. Market Challenges
      • 3.3.1. Lack of Awareness in Developing Countries
    • 3.4. Market Trends
      • 3.4.1. Emergence of Cost Effective Technologies and Laboratory Automation
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Competitive ELISA, by Type, Application, ELISA and Region (value, volume and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Competitive ELISA (Value)
      • 5.2.1. Global Competitive ELISA by: Type (Value)
        • 5.2.1.1. ELISA Sets
        • 5.2.1.2. ELISA Kits
      • 5.2.2. Global Competitive ELISA by: Application (Value)
        • 5.2.2.1. Vaccine Development
        • 5.2.2.2. Immunology
        • 5.2.2.3. Diagnostics
        • 5.2.2.4. Toxicology
        • 5.2.2.5. Drug Development and Pharmaceutical Industry
        • 5.2.2.6. Transplantation
        • 5.2.2.7. Other
      • 5.2.3. Global Competitive ELISA by: ELISA (Value)
        • 5.2.3.1. Direct ELISA
        • 5.2.3.2. Sandwich ELISA
        • 5.2.3.3. Competitive ELISA
        • 5.2.3.4. Reverse ELISA
      • 5.2.4. Global Competitive ELISA Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Competitive ELISA (Volume)
      • 5.3.1. Global Competitive ELISA by: Type (Volume)
        • 5.3.1.1. ELISA Sets
        • 5.3.1.2. ELISA Kits
      • 5.3.2. Global Competitive ELISA by: Application (Volume)
        • 5.3.2.1. Vaccine Development
        • 5.3.2.2. Immunology
        • 5.3.2.3. Diagnostics
        • 5.3.2.4. Toxicology
        • 5.3.2.5. Drug Development and Pharmaceutical Industry
        • 5.3.2.6. Transplantation
        • 5.3.2.7. Other
      • 5.3.3. Global Competitive ELISA by: ELISA (Volume)
        • 5.3.3.1. Direct ELISA
        • 5.3.3.2. Sandwich ELISA
        • 5.3.3.3. Competitive ELISA
        • 5.3.3.4. Reverse ELISA
      • 5.3.4. Global Competitive ELISA Region
        • 5.3.4.1. South America
          • 5.3.4.1.1. Brazil
          • 5.3.4.1.2. Argentina
          • 5.3.4.1.3. Rest of South America
        • 5.3.4.2. Asia Pacific
          • 5.3.4.2.1. China
          • 5.3.4.2.2. Japan
          • 5.3.4.2.3. India
          • 5.3.4.2.4. South Korea
          • 5.3.4.2.5. Taiwan
          • 5.3.4.2.6. Australia
          • 5.3.4.2.7. Rest of Asia-Pacific
        • 5.3.4.3. Europe
          • 5.3.4.3.1. Germany
          • 5.3.4.3.2. France
          • 5.3.4.3.3. Italy
          • 5.3.4.3.4. United Kingdom
          • 5.3.4.3.5. Netherlands
          • 5.3.4.3.6. Rest of Europe
        • 5.3.4.4. MEA
          • 5.3.4.4.1. Middle East
          • 5.3.4.4.2. Africa
        • 5.3.4.5. North America
          • 5.3.4.5.1. United States
          • 5.3.4.5.2. Canada
          • 5.3.4.5.3. Mexico
    • 5.4. Global Competitive ELISA (Price)
      • 5.4.1. Global Competitive ELISA by: Type (Price)
  • 6. Competitive ELISA: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Bio-Rad Laboratories (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Fisher Scientific (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Cell Biolabs, Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Enzo Life Sciences, Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Sino Biological Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. BioVision, Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Invitrogen (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Hycult Biotech (Netherlands)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Biomerieux (France)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. ALPCO (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Competitive ELISA Sale, by Type, Application, ELISA and Region (value, volume and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Competitive ELISA (Value)
      • 7.2.1. Global Competitive ELISA by: Type (Value)
        • 7.2.1.1. ELISA Sets
        • 7.2.1.2. ELISA Kits
      • 7.2.2. Global Competitive ELISA by: Application (Value)
        • 7.2.2.1. Vaccine Development
        • 7.2.2.2. Immunology
        • 7.2.2.3. Diagnostics
        • 7.2.2.4. Toxicology
        • 7.2.2.5. Drug Development and Pharmaceutical Industry
        • 7.2.2.6. Transplantation
        • 7.2.2.7. Other
      • 7.2.3. Global Competitive ELISA by: ELISA (Value)
        • 7.2.3.1. Direct ELISA
        • 7.2.3.2. Sandwich ELISA
        • 7.2.3.3. Competitive ELISA
        • 7.2.3.4. Reverse ELISA
      • 7.2.4. Global Competitive ELISA Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Competitive ELISA (Volume)
      • 7.3.1. Global Competitive ELISA by: Type (Volume)
        • 7.3.1.1. ELISA Sets
        • 7.3.1.2. ELISA Kits
      • 7.3.2. Global Competitive ELISA by: Application (Volume)
        • 7.3.2.1. Vaccine Development
        • 7.3.2.2. Immunology
        • 7.3.2.3. Diagnostics
        • 7.3.2.4. Toxicology
        • 7.3.2.5. Drug Development and Pharmaceutical Industry
        • 7.3.2.6. Transplantation
        • 7.3.2.7. Other
      • 7.3.3. Global Competitive ELISA by: ELISA (Volume)
        • 7.3.3.1. Direct ELISA
        • 7.3.3.2. Sandwich ELISA
        • 7.3.3.3. Competitive ELISA
        • 7.3.3.4. Reverse ELISA
      • 7.3.4. Global Competitive ELISA Region
        • 7.3.4.1. South America
          • 7.3.4.1.1. Brazil
          • 7.3.4.1.2. Argentina
          • 7.3.4.1.3. Rest of South America
        • 7.3.4.2. Asia Pacific
          • 7.3.4.2.1. China
          • 7.3.4.2.2. Japan
          • 7.3.4.2.3. India
          • 7.3.4.2.4. South Korea
          • 7.3.4.2.5. Taiwan
          • 7.3.4.2.6. Australia
          • 7.3.4.2.7. Rest of Asia-Pacific
        • 7.3.4.3. Europe
          • 7.3.4.3.1. Germany
          • 7.3.4.3.2. France
          • 7.3.4.3.3. Italy
          • 7.3.4.3.4. United Kingdom
          • 7.3.4.3.5. Netherlands
          • 7.3.4.3.6. Rest of Europe
        • 7.3.4.4. MEA
          • 7.3.4.4.1. Middle East
          • 7.3.4.4.2. Africa
        • 7.3.4.5. North America
          • 7.3.4.5.1. United States
          • 7.3.4.5.2. Canada
          • 7.3.4.5.3. Mexico
    • 7.4. Global Competitive ELISA (Price)
      • 7.4.1. Global Competitive ELISA by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Competitive ELISA: by Type(USD Million)
  • Table 2. Competitive ELISA ELISA Sets , by Region USD Million (2018-2023)
  • Table 3. Competitive ELISA ELISA Kits , by Region USD Million (2018-2023)
  • Table 4. Competitive ELISA: by Application(USD Million)
  • Table 5. Competitive ELISA Vaccine Development , by Region USD Million (2018-2023)
  • Table 6. Competitive ELISA Immunology , by Region USD Million (2018-2023)
  • Table 7. Competitive ELISA Diagnostics , by Region USD Million (2018-2023)
  • Table 8. Competitive ELISA Toxicology , by Region USD Million (2018-2023)
  • Table 9. Competitive ELISA Drug Development and Pharmaceutical Industry , by Region USD Million (2018-2023)
  • Table 10. Competitive ELISA Transplantation , by Region USD Million (2018-2023)
  • Table 11. Competitive ELISA Other , by Region USD Million (2018-2023)
  • Table 12. Competitive ELISA: by ELISA(USD Million)
  • Table 13. Competitive ELISA Direct ELISA , by Region USD Million (2018-2023)
  • Table 14. Competitive ELISA Sandwich ELISA , by Region USD Million (2018-2023)
  • Table 15. Competitive ELISA Competitive ELISA , by Region USD Million (2018-2023)
  • Table 16. Competitive ELISA Reverse ELISA , by Region USD Million (2018-2023)
  • Table 17. South America Competitive ELISA, by Country USD Million (2018-2023)
  • Table 18. South America Competitive ELISA, by Type USD Million (2018-2023)
  • Table 19. South America Competitive ELISA, by Application USD Million (2018-2023)
  • Table 20. South America Competitive ELISA, by ELISA USD Million (2018-2023)
  • Table 21. Brazil Competitive ELISA, by Type USD Million (2018-2023)
  • Table 22. Brazil Competitive ELISA, by Application USD Million (2018-2023)
  • Table 23. Brazil Competitive ELISA, by ELISA USD Million (2018-2023)
  • Table 24. Argentina Competitive ELISA, by Type USD Million (2018-2023)
  • Table 25. Argentina Competitive ELISA, by Application USD Million (2018-2023)
  • Table 26. Argentina Competitive ELISA, by ELISA USD Million (2018-2023)
  • Table 27. Rest of South America Competitive ELISA, by Type USD Million (2018-2023)
  • Table 28. Rest of South America Competitive ELISA, by Application USD Million (2018-2023)
  • Table 29. Rest of South America Competitive ELISA, by ELISA USD Million (2018-2023)
  • Table 30. Asia Pacific Competitive ELISA, by Country USD Million (2018-2023)
  • Table 31. Asia Pacific Competitive ELISA, by Type USD Million (2018-2023)
  • Table 32. Asia Pacific Competitive ELISA, by Application USD Million (2018-2023)
  • Table 33. Asia Pacific Competitive ELISA, by ELISA USD Million (2018-2023)
  • Table 34. China Competitive ELISA, by Type USD Million (2018-2023)
  • Table 35. China Competitive ELISA, by Application USD Million (2018-2023)
  • Table 36. China Competitive ELISA, by ELISA USD Million (2018-2023)
  • Table 37. Japan Competitive ELISA, by Type USD Million (2018-2023)
  • Table 38. Japan Competitive ELISA, by Application USD Million (2018-2023)
  • Table 39. Japan Competitive ELISA, by ELISA USD Million (2018-2023)
  • Table 40. India Competitive ELISA, by Type USD Million (2018-2023)
  • Table 41. India Competitive ELISA, by Application USD Million (2018-2023)
  • Table 42. India Competitive ELISA, by ELISA USD Million (2018-2023)
  • Table 43. South Korea Competitive ELISA, by Type USD Million (2018-2023)
  • Table 44. South Korea Competitive ELISA, by Application USD Million (2018-2023)
  • Table 45. South Korea Competitive ELISA, by ELISA USD Million (2018-2023)
  • Table 46. Taiwan Competitive ELISA, by Type USD Million (2018-2023)
  • Table 47. Taiwan Competitive ELISA, by Application USD Million (2018-2023)
  • Table 48. Taiwan Competitive ELISA, by ELISA USD Million (2018-2023)
  • Table 49. Australia Competitive ELISA, by Type USD Million (2018-2023)
  • Table 50. Australia Competitive ELISA, by Application USD Million (2018-2023)
  • Table 51. Australia Competitive ELISA, by ELISA USD Million (2018-2023)
  • Table 52. Rest of Asia-Pacific Competitive ELISA, by Type USD Million (2018-2023)
  • Table 53. Rest of Asia-Pacific Competitive ELISA, by Application USD Million (2018-2023)
  • Table 54. Rest of Asia-Pacific Competitive ELISA, by ELISA USD Million (2018-2023)
  • Table 55. Europe Competitive ELISA, by Country USD Million (2018-2023)
  • Table 56. Europe Competitive ELISA, by Type USD Million (2018-2023)
  • Table 57. Europe Competitive ELISA, by Application USD Million (2018-2023)
  • Table 58. Europe Competitive ELISA, by ELISA USD Million (2018-2023)
  • Table 59. Germany Competitive ELISA, by Type USD Million (2018-2023)
  • Table 60. Germany Competitive ELISA, by Application USD Million (2018-2023)
  • Table 61. Germany Competitive ELISA, by ELISA USD Million (2018-2023)
  • Table 62. France Competitive ELISA, by Type USD Million (2018-2023)
  • Table 63. France Competitive ELISA, by Application USD Million (2018-2023)
  • Table 64. France Competitive ELISA, by ELISA USD Million (2018-2023)
  • Table 65. Italy Competitive ELISA, by Type USD Million (2018-2023)
  • Table 66. Italy Competitive ELISA, by Application USD Million (2018-2023)
  • Table 67. Italy Competitive ELISA, by ELISA USD Million (2018-2023)
  • Table 68. United Kingdom Competitive ELISA, by Type USD Million (2018-2023)
  • Table 69. United Kingdom Competitive ELISA, by Application USD Million (2018-2023)
  • Table 70. United Kingdom Competitive ELISA, by ELISA USD Million (2018-2023)
  • Table 71. Netherlands Competitive ELISA, by Type USD Million (2018-2023)
  • Table 72. Netherlands Competitive ELISA, by Application USD Million (2018-2023)
  • Table 73. Netherlands Competitive ELISA, by ELISA USD Million (2018-2023)
  • Table 74. Rest of Europe Competitive ELISA, by Type USD Million (2018-2023)
  • Table 75. Rest of Europe Competitive ELISA, by Application USD Million (2018-2023)
  • Table 76. Rest of Europe Competitive ELISA, by ELISA USD Million (2018-2023)
  • Table 77. MEA Competitive ELISA, by Country USD Million (2018-2023)
  • Table 78. MEA Competitive ELISA, by Type USD Million (2018-2023)
  • Table 79. MEA Competitive ELISA, by Application USD Million (2018-2023)
  • Table 80. MEA Competitive ELISA, by ELISA USD Million (2018-2023)
  • Table 81. Middle East Competitive ELISA, by Type USD Million (2018-2023)
  • Table 82. Middle East Competitive ELISA, by Application USD Million (2018-2023)
  • Table 83. Middle East Competitive ELISA, by ELISA USD Million (2018-2023)
  • Table 84. Africa Competitive ELISA, by Type USD Million (2018-2023)
  • Table 85. Africa Competitive ELISA, by Application USD Million (2018-2023)
  • Table 86. Africa Competitive ELISA, by ELISA USD Million (2018-2023)
  • Table 87. North America Competitive ELISA, by Country USD Million (2018-2023)
  • Table 88. North America Competitive ELISA, by Type USD Million (2018-2023)
  • Table 89. North America Competitive ELISA, by Application USD Million (2018-2023)
  • Table 90. North America Competitive ELISA, by ELISA USD Million (2018-2023)
  • Table 91. United States Competitive ELISA, by Type USD Million (2018-2023)
  • Table 92. United States Competitive ELISA, by Application USD Million (2018-2023)
  • Table 93. United States Competitive ELISA, by ELISA USD Million (2018-2023)
  • Table 94. Canada Competitive ELISA, by Type USD Million (2018-2023)
  • Table 95. Canada Competitive ELISA, by Application USD Million (2018-2023)
  • Table 96. Canada Competitive ELISA, by ELISA USD Million (2018-2023)
  • Table 97. Mexico Competitive ELISA, by Type USD Million (2018-2023)
  • Table 98. Mexico Competitive ELISA, by Application USD Million (2018-2023)
  • Table 99. Mexico Competitive ELISA, by ELISA USD Million (2018-2023)
  • Table 100. Competitive ELISA Sales: by Type(Units)
  • Table 101. Competitive ELISA Sales ELISA Sets , by Region Units (2018-2023)
  • Table 102. Competitive ELISA Sales ELISA Kits , by Region Units (2018-2023)
  • Table 103. Competitive ELISA Sales: by Application(Units)
  • Table 104. Competitive ELISA Sales Vaccine Development , by Region Units (2018-2023)
  • Table 105. Competitive ELISA Sales Immunology , by Region Units (2018-2023)
  • Table 106. Competitive ELISA Sales Diagnostics , by Region Units (2018-2023)
  • Table 107. Competitive ELISA Sales Toxicology , by Region Units (2018-2023)
  • Table 108. Competitive ELISA Sales Drug Development and Pharmaceutical Industry , by Region Units (2018-2023)
  • Table 109. Competitive ELISA Sales Transplantation , by Region Units (2018-2023)
  • Table 110. Competitive ELISA Sales Other , by Region Units (2018-2023)
  • Table 111. Competitive ELISA Sales: by ELISA(Units)
  • Table 112. Competitive ELISA Sales Direct ELISA , by Region Units (2018-2023)
  • Table 113. Competitive ELISA Sales Sandwich ELISA , by Region Units (2018-2023)
  • Table 114. Competitive ELISA Sales Competitive ELISA , by Region Units (2018-2023)
  • Table 115. Competitive ELISA Sales Reverse ELISA , by Region Units (2018-2023)
  • Table 116. South America Competitive ELISA Sales, by Country Units (2018-2023)
  • Table 117. South America Competitive ELISA Sales, by Type Units (2018-2023)
  • Table 118. South America Competitive ELISA Sales, by Application Units (2018-2023)
  • Table 119. South America Competitive ELISA Sales, by ELISA Units (2018-2023)
  • Table 120. Brazil Competitive ELISA Sales, by Type Units (2018-2023)
  • Table 121. Brazil Competitive ELISA Sales, by Application Units (2018-2023)
  • Table 122. Brazil Competitive ELISA Sales, by ELISA Units (2018-2023)
  • Table 123. Argentina Competitive ELISA Sales, by Type Units (2018-2023)
  • Table 124. Argentina Competitive ELISA Sales, by Application Units (2018-2023)
  • Table 125. Argentina Competitive ELISA Sales, by ELISA Units (2018-2023)
  • Table 126. Rest of South America Competitive ELISA Sales, by Type Units (2018-2023)
  • Table 127. Rest of South America Competitive ELISA Sales, by Application Units (2018-2023)
  • Table 128. Rest of South America Competitive ELISA Sales, by ELISA Units (2018-2023)
  • Table 129. Asia Pacific Competitive ELISA Sales, by Country Units (2018-2023)
  • Table 130. Asia Pacific Competitive ELISA Sales, by Type Units (2018-2023)
  • Table 131. Asia Pacific Competitive ELISA Sales, by Application Units (2018-2023)
  • Table 132. Asia Pacific Competitive ELISA Sales, by ELISA Units (2018-2023)
  • Table 133. China Competitive ELISA Sales, by Type Units (2018-2023)
  • Table 134. China Competitive ELISA Sales, by Application Units (2018-2023)
  • Table 135. China Competitive ELISA Sales, by ELISA Units (2018-2023)
  • Table 136. Japan Competitive ELISA Sales, by Type Units (2018-2023)
  • Table 137. Japan Competitive ELISA Sales, by Application Units (2018-2023)
  • Table 138. Japan Competitive ELISA Sales, by ELISA Units (2018-2023)
  • Table 139. India Competitive ELISA Sales, by Type Units (2018-2023)
  • Table 140. India Competitive ELISA Sales, by Application Units (2018-2023)
  • Table 141. India Competitive ELISA Sales, by ELISA Units (2018-2023)
  • Table 142. South Korea Competitive ELISA Sales, by Type Units (2018-2023)
  • Table 143. South Korea Competitive ELISA Sales, by Application Units (2018-2023)
  • Table 144. South Korea Competitive ELISA Sales, by ELISA Units (2018-2023)
  • Table 145. Taiwan Competitive ELISA Sales, by Type Units (2018-2023)
  • Table 146. Taiwan Competitive ELISA Sales, by Application Units (2018-2023)
  • Table 147. Taiwan Competitive ELISA Sales, by ELISA Units (2018-2023)
  • Table 148. Australia Competitive ELISA Sales, by Type Units (2018-2023)
  • Table 149. Australia Competitive ELISA Sales, by Application Units (2018-2023)
  • Table 150. Australia Competitive ELISA Sales, by ELISA Units (2018-2023)
  • Table 151. Rest of Asia-Pacific Competitive ELISA Sales, by Type Units (2018-2023)
  • Table 152. Rest of Asia-Pacific Competitive ELISA Sales, by Application Units (2018-2023)
  • Table 153. Rest of Asia-Pacific Competitive ELISA Sales, by ELISA Units (2018-2023)
  • Table 154. Europe Competitive ELISA Sales, by Country Units (2018-2023)
  • Table 155. Europe Competitive ELISA Sales, by Type Units (2018-2023)
  • Table 156. Europe Competitive ELISA Sales, by Application Units (2018-2023)
  • Table 157. Europe Competitive ELISA Sales, by ELISA Units (2018-2023)
  • Table 158. Germany Competitive ELISA Sales, by Type Units (2018-2023)
  • Table 159. Germany Competitive ELISA Sales, by Application Units (2018-2023)
  • Table 160. Germany Competitive ELISA Sales, by ELISA Units (2018-2023)
  • Table 161. France Competitive ELISA Sales, by Type Units (2018-2023)
  • Table 162. France Competitive ELISA Sales, by Application Units (2018-2023)
  • Table 163. France Competitive ELISA Sales, by ELISA Units (2018-2023)
  • Table 164. Italy Competitive ELISA Sales, by Type Units (2018-2023)
  • Table 165. Italy Competitive ELISA Sales, by Application Units (2018-2023)
  • Table 166. Italy Competitive ELISA Sales, by ELISA Units (2018-2023)
  • Table 167. United Kingdom Competitive ELISA Sales, by Type Units (2018-2023)
  • Table 168. United Kingdom Competitive ELISA Sales, by Application Units (2018-2023)
  • Table 169. United Kingdom Competitive ELISA Sales, by ELISA Units (2018-2023)
  • Table 170. Netherlands Competitive ELISA Sales, by Type Units (2018-2023)
  • Table 171. Netherlands Competitive ELISA Sales, by Application Units (2018-2023)
  • Table 172. Netherlands Competitive ELISA Sales, by ELISA Units (2018-2023)
  • Table 173. Rest of Europe Competitive ELISA Sales, by Type Units (2018-2023)
  • Table 174. Rest of Europe Competitive ELISA Sales, by Application Units (2018-2023)
  • Table 175. Rest of Europe Competitive ELISA Sales, by ELISA Units (2018-2023)
  • Table 176. MEA Competitive ELISA Sales, by Country Units (2018-2023)
  • Table 177. MEA Competitive ELISA Sales, by Type Units (2018-2023)
  • Table 178. MEA Competitive ELISA Sales, by Application Units (2018-2023)
  • Table 179. MEA Competitive ELISA Sales, by ELISA Units (2018-2023)
  • Table 180. Middle East Competitive ELISA Sales, by Type Units (2018-2023)
  • Table 181. Middle East Competitive ELISA Sales, by Application Units (2018-2023)
  • Table 182. Middle East Competitive ELISA Sales, by ELISA Units (2018-2023)
  • Table 183. Africa Competitive ELISA Sales, by Type Units (2018-2023)
  • Table 184. Africa Competitive ELISA Sales, by Application Units (2018-2023)
  • Table 185. Africa Competitive ELISA Sales, by ELISA Units (2018-2023)
  • Table 186. North America Competitive ELISA Sales, by Country Units (2018-2023)
  • Table 187. North America Competitive ELISA Sales, by Type Units (2018-2023)
  • Table 188. North America Competitive ELISA Sales, by Application Units (2018-2023)
  • Table 189. North America Competitive ELISA Sales, by ELISA Units (2018-2023)
  • Table 190. United States Competitive ELISA Sales, by Type Units (2018-2023)
  • Table 191. United States Competitive ELISA Sales, by Application Units (2018-2023)
  • Table 192. United States Competitive ELISA Sales, by ELISA Units (2018-2023)
  • Table 193. Canada Competitive ELISA Sales, by Type Units (2018-2023)
  • Table 194. Canada Competitive ELISA Sales, by Application Units (2018-2023)
  • Table 195. Canada Competitive ELISA Sales, by ELISA Units (2018-2023)
  • Table 196. Mexico Competitive ELISA Sales, by Type Units (2018-2023)
  • Table 197. Mexico Competitive ELISA Sales, by Application Units (2018-2023)
  • Table 198. Mexico Competitive ELISA Sales, by ELISA Units (2018-2023)
  • Table 199. Competitive ELISA: by Type(USD/Units)
  • Table 200. Company Basic Information, Sales Area and Its Competitors
  • Table 201. Company Basic Information, Sales Area and Its Competitors
  • Table 202. Company Basic Information, Sales Area and Its Competitors
  • Table 203. Company Basic Information, Sales Area and Its Competitors
  • Table 204. Company Basic Information, Sales Area and Its Competitors
  • Table 205. Company Basic Information, Sales Area and Its Competitors
  • Table 206. Company Basic Information, Sales Area and Its Competitors
  • Table 207. Company Basic Information, Sales Area and Its Competitors
  • Table 208. Company Basic Information, Sales Area and Its Competitors
  • Table 209. Company Basic Information, Sales Area and Its Competitors
  • Table 210. Competitive ELISA: by Type(USD Million)
  • Table 211. Competitive ELISA ELISA Sets , by Region USD Million (2025-2030)
  • Table 212. Competitive ELISA ELISA Kits , by Region USD Million (2025-2030)
  • Table 213. Competitive ELISA: by Application(USD Million)
  • Table 214. Competitive ELISA Vaccine Development , by Region USD Million (2025-2030)
  • Table 215. Competitive ELISA Immunology , by Region USD Million (2025-2030)
  • Table 216. Competitive ELISA Diagnostics , by Region USD Million (2025-2030)
  • Table 217. Competitive ELISA Toxicology , by Region USD Million (2025-2030)
  • Table 218. Competitive ELISA Drug Development and Pharmaceutical Industry , by Region USD Million (2025-2030)
  • Table 219. Competitive ELISA Transplantation , by Region USD Million (2025-2030)
  • Table 220. Competitive ELISA Other , by Region USD Million (2025-2030)
  • Table 221. Competitive ELISA: by ELISA(USD Million)
  • Table 222. Competitive ELISA Direct ELISA , by Region USD Million (2025-2030)
  • Table 223. Competitive ELISA Sandwich ELISA , by Region USD Million (2025-2030)
  • Table 224. Competitive ELISA Competitive ELISA , by Region USD Million (2025-2030)
  • Table 225. Competitive ELISA Reverse ELISA , by Region USD Million (2025-2030)
  • Table 226. South America Competitive ELISA, by Country USD Million (2025-2030)
  • Table 227. South America Competitive ELISA, by Type USD Million (2025-2030)
  • Table 228. South America Competitive ELISA, by Application USD Million (2025-2030)
  • Table 229. South America Competitive ELISA, by ELISA USD Million (2025-2030)
  • Table 230. Brazil Competitive ELISA, by Type USD Million (2025-2030)
  • Table 231. Brazil Competitive ELISA, by Application USD Million (2025-2030)
  • Table 232. Brazil Competitive ELISA, by ELISA USD Million (2025-2030)
  • Table 233. Argentina Competitive ELISA, by Type USD Million (2025-2030)
  • Table 234. Argentina Competitive ELISA, by Application USD Million (2025-2030)
  • Table 235. Argentina Competitive ELISA, by ELISA USD Million (2025-2030)
  • Table 236. Rest of South America Competitive ELISA, by Type USD Million (2025-2030)
  • Table 237. Rest of South America Competitive ELISA, by Application USD Million (2025-2030)
  • Table 238. Rest of South America Competitive ELISA, by ELISA USD Million (2025-2030)
  • Table 239. Asia Pacific Competitive ELISA, by Country USD Million (2025-2030)
  • Table 240. Asia Pacific Competitive ELISA, by Type USD Million (2025-2030)
  • Table 241. Asia Pacific Competitive ELISA, by Application USD Million (2025-2030)
  • Table 242. Asia Pacific Competitive ELISA, by ELISA USD Million (2025-2030)
  • Table 243. China Competitive ELISA, by Type USD Million (2025-2030)
  • Table 244. China Competitive ELISA, by Application USD Million (2025-2030)
  • Table 245. China Competitive ELISA, by ELISA USD Million (2025-2030)
  • Table 246. Japan Competitive ELISA, by Type USD Million (2025-2030)
  • Table 247. Japan Competitive ELISA, by Application USD Million (2025-2030)
  • Table 248. Japan Competitive ELISA, by ELISA USD Million (2025-2030)
  • Table 249. India Competitive ELISA, by Type USD Million (2025-2030)
  • Table 250. India Competitive ELISA, by Application USD Million (2025-2030)
  • Table 251. India Competitive ELISA, by ELISA USD Million (2025-2030)
  • Table 252. South Korea Competitive ELISA, by Type USD Million (2025-2030)
  • Table 253. South Korea Competitive ELISA, by Application USD Million (2025-2030)
  • Table 254. South Korea Competitive ELISA, by ELISA USD Million (2025-2030)
  • Table 255. Taiwan Competitive ELISA, by Type USD Million (2025-2030)
  • Table 256. Taiwan Competitive ELISA, by Application USD Million (2025-2030)
  • Table 257. Taiwan Competitive ELISA, by ELISA USD Million (2025-2030)
  • Table 258. Australia Competitive ELISA, by Type USD Million (2025-2030)
  • Table 259. Australia Competitive ELISA, by Application USD Million (2025-2030)
  • Table 260. Australia Competitive ELISA, by ELISA USD Million (2025-2030)
  • Table 261. Rest of Asia-Pacific Competitive ELISA, by Type USD Million (2025-2030)
  • Table 262. Rest of Asia-Pacific Competitive ELISA, by Application USD Million (2025-2030)
  • Table 263. Rest of Asia-Pacific Competitive ELISA, by ELISA USD Million (2025-2030)
  • Table 264. Europe Competitive ELISA, by Country USD Million (2025-2030)
  • Table 265. Europe Competitive ELISA, by Type USD Million (2025-2030)
  • Table 266. Europe Competitive ELISA, by Application USD Million (2025-2030)
  • Table 267. Europe Competitive ELISA, by ELISA USD Million (2025-2030)
  • Table 268. Germany Competitive ELISA, by Type USD Million (2025-2030)
  • Table 269. Germany Competitive ELISA, by Application USD Million (2025-2030)
  • Table 270. Germany Competitive ELISA, by ELISA USD Million (2025-2030)
  • Table 271. France Competitive ELISA, by Type USD Million (2025-2030)
  • Table 272. France Competitive ELISA, by Application USD Million (2025-2030)
  • Table 273. France Competitive ELISA, by ELISA USD Million (2025-2030)
  • Table 274. Italy Competitive ELISA, by Type USD Million (2025-2030)
  • Table 275. Italy Competitive ELISA, by Application USD Million (2025-2030)
  • Table 276. Italy Competitive ELISA, by ELISA USD Million (2025-2030)
  • Table 277. United Kingdom Competitive ELISA, by Type USD Million (2025-2030)
  • Table 278. United Kingdom Competitive ELISA, by Application USD Million (2025-2030)
  • Table 279. United Kingdom Competitive ELISA, by ELISA USD Million (2025-2030)
  • Table 280. Netherlands Competitive ELISA, by Type USD Million (2025-2030)
  • Table 281. Netherlands Competitive ELISA, by Application USD Million (2025-2030)
  • Table 282. Netherlands Competitive ELISA, by ELISA USD Million (2025-2030)
  • Table 283. Rest of Europe Competitive ELISA, by Type USD Million (2025-2030)
  • Table 284. Rest of Europe Competitive ELISA, by Application USD Million (2025-2030)
  • Table 285. Rest of Europe Competitive ELISA, by ELISA USD Million (2025-2030)
  • Table 286. MEA Competitive ELISA, by Country USD Million (2025-2030)
  • Table 287. MEA Competitive ELISA, by Type USD Million (2025-2030)
  • Table 288. MEA Competitive ELISA, by Application USD Million (2025-2030)
  • Table 289. MEA Competitive ELISA, by ELISA USD Million (2025-2030)
  • Table 290. Middle East Competitive ELISA, by Type USD Million (2025-2030)
  • Table 291. Middle East Competitive ELISA, by Application USD Million (2025-2030)
  • Table 292. Middle East Competitive ELISA, by ELISA USD Million (2025-2030)
  • Table 293. Africa Competitive ELISA, by Type USD Million (2025-2030)
  • Table 294. Africa Competitive ELISA, by Application USD Million (2025-2030)
  • Table 295. Africa Competitive ELISA, by ELISA USD Million (2025-2030)
  • Table 296. North America Competitive ELISA, by Country USD Million (2025-2030)
  • Table 297. North America Competitive ELISA, by Type USD Million (2025-2030)
  • Table 298. North America Competitive ELISA, by Application USD Million (2025-2030)
  • Table 299. North America Competitive ELISA, by ELISA USD Million (2025-2030)
  • Table 300. United States Competitive ELISA, by Type USD Million (2025-2030)
  • Table 301. United States Competitive ELISA, by Application USD Million (2025-2030)
  • Table 302. United States Competitive ELISA, by ELISA USD Million (2025-2030)
  • Table 303. Canada Competitive ELISA, by Type USD Million (2025-2030)
  • Table 304. Canada Competitive ELISA, by Application USD Million (2025-2030)
  • Table 305. Canada Competitive ELISA, by ELISA USD Million (2025-2030)
  • Table 306. Mexico Competitive ELISA, by Type USD Million (2025-2030)
  • Table 307. Mexico Competitive ELISA, by Application USD Million (2025-2030)
  • Table 308. Mexico Competitive ELISA, by ELISA USD Million (2025-2030)
  • Table 309. Competitive ELISA Sales: by Type(Units)
  • Table 310. Competitive ELISA Sales ELISA Sets , by Region Units (2025-2030)
  • Table 311. Competitive ELISA Sales ELISA Kits , by Region Units (2025-2030)
  • Table 312. Competitive ELISA Sales: by Application(Units)
  • Table 313. Competitive ELISA Sales Vaccine Development , by Region Units (2025-2030)
  • Table 314. Competitive ELISA Sales Immunology , by Region Units (2025-2030)
  • Table 315. Competitive ELISA Sales Diagnostics , by Region Units (2025-2030)
  • Table 316. Competitive ELISA Sales Toxicology , by Region Units (2025-2030)
  • Table 317. Competitive ELISA Sales Drug Development and Pharmaceutical Industry , by Region Units (2025-2030)
  • Table 318. Competitive ELISA Sales Transplantation , by Region Units (2025-2030)
  • Table 319. Competitive ELISA Sales Other , by Region Units (2025-2030)
  • Table 320. Competitive ELISA Sales: by ELISA(Units)
  • Table 321. Competitive ELISA Sales Direct ELISA , by Region Units (2025-2030)
  • Table 322. Competitive ELISA Sales Sandwich ELISA , by Region Units (2025-2030)
  • Table 323. Competitive ELISA Sales Competitive ELISA , by Region Units (2025-2030)
  • Table 324. Competitive ELISA Sales Reverse ELISA , by Region Units (2025-2030)
  • Table 325. South America Competitive ELISA Sales, by Country Units (2025-2030)
  • Table 326. South America Competitive ELISA Sales, by Type Units (2025-2030)
  • Table 327. South America Competitive ELISA Sales, by Application Units (2025-2030)
  • Table 328. South America Competitive ELISA Sales, by ELISA Units (2025-2030)
  • Table 329. Brazil Competitive ELISA Sales, by Type Units (2025-2030)
  • Table 330. Brazil Competitive ELISA Sales, by Application Units (2025-2030)
  • Table 331. Brazil Competitive ELISA Sales, by ELISA Units (2025-2030)
  • Table 332. Argentina Competitive ELISA Sales, by Type Units (2025-2030)
  • Table 333. Argentina Competitive ELISA Sales, by Application Units (2025-2030)
  • Table 334. Argentina Competitive ELISA Sales, by ELISA Units (2025-2030)
  • Table 335. Rest of South America Competitive ELISA Sales, by Type Units (2025-2030)
  • Table 336. Rest of South America Competitive ELISA Sales, by Application Units (2025-2030)
  • Table 337. Rest of South America Competitive ELISA Sales, by ELISA Units (2025-2030)
  • Table 338. Asia Pacific Competitive ELISA Sales, by Country Units (2025-2030)
  • Table 339. Asia Pacific Competitive ELISA Sales, by Type Units (2025-2030)
  • Table 340. Asia Pacific Competitive ELISA Sales, by Application Units (2025-2030)
  • Table 341. Asia Pacific Competitive ELISA Sales, by ELISA Units (2025-2030)
  • Table 342. China Competitive ELISA Sales, by Type Units (2025-2030)
  • Table 343. China Competitive ELISA Sales, by Application Units (2025-2030)
  • Table 344. China Competitive ELISA Sales, by ELISA Units (2025-2030)
  • Table 345. Japan Competitive ELISA Sales, by Type Units (2025-2030)
  • Table 346. Japan Competitive ELISA Sales, by Application Units (2025-2030)
  • Table 347. Japan Competitive ELISA Sales, by ELISA Units (2025-2030)
  • Table 348. India Competitive ELISA Sales, by Type Units (2025-2030)
  • Table 349. India Competitive ELISA Sales, by Application Units (2025-2030)
  • Table 350. India Competitive ELISA Sales, by ELISA Units (2025-2030)
  • Table 351. South Korea Competitive ELISA Sales, by Type Units (2025-2030)
  • Table 352. South Korea Competitive ELISA Sales, by Application Units (2025-2030)
  • Table 353. South Korea Competitive ELISA Sales, by ELISA Units (2025-2030)
  • Table 354. Taiwan Competitive ELISA Sales, by Type Units (2025-2030)
  • Table 355. Taiwan Competitive ELISA Sales, by Application Units (2025-2030)
  • Table 356. Taiwan Competitive ELISA Sales, by ELISA Units (2025-2030)
  • Table 357. Australia Competitive ELISA Sales, by Type Units (2025-2030)
  • Table 358. Australia Competitive ELISA Sales, by Application Units (2025-2030)
  • Table 359. Australia Competitive ELISA Sales, by ELISA Units (2025-2030)
  • Table 360. Rest of Asia-Pacific Competitive ELISA Sales, by Type Units (2025-2030)
  • Table 361. Rest of Asia-Pacific Competitive ELISA Sales, by Application Units (2025-2030)
  • Table 362. Rest of Asia-Pacific Competitive ELISA Sales, by ELISA Units (2025-2030)
  • Table 363. Europe Competitive ELISA Sales, by Country Units (2025-2030)
  • Table 364. Europe Competitive ELISA Sales, by Type Units (2025-2030)
  • Table 365. Europe Competitive ELISA Sales, by Application Units (2025-2030)
  • Table 366. Europe Competitive ELISA Sales, by ELISA Units (2025-2030)
  • Table 367. Germany Competitive ELISA Sales, by Type Units (2025-2030)
  • Table 368. Germany Competitive ELISA Sales, by Application Units (2025-2030)
  • Table 369. Germany Competitive ELISA Sales, by ELISA Units (2025-2030)
  • Table 370. France Competitive ELISA Sales, by Type Units (2025-2030)
  • Table 371. France Competitive ELISA Sales, by Application Units (2025-2030)
  • Table 372. France Competitive ELISA Sales, by ELISA Units (2025-2030)
  • Table 373. Italy Competitive ELISA Sales, by Type Units (2025-2030)
  • Table 374. Italy Competitive ELISA Sales, by Application Units (2025-2030)
  • Table 375. Italy Competitive ELISA Sales, by ELISA Units (2025-2030)
  • Table 376. United Kingdom Competitive ELISA Sales, by Type Units (2025-2030)
  • Table 377. United Kingdom Competitive ELISA Sales, by Application Units (2025-2030)
  • Table 378. United Kingdom Competitive ELISA Sales, by ELISA Units (2025-2030)
  • Table 379. Netherlands Competitive ELISA Sales, by Type Units (2025-2030)
  • Table 380. Netherlands Competitive ELISA Sales, by Application Units (2025-2030)
  • Table 381. Netherlands Competitive ELISA Sales, by ELISA Units (2025-2030)
  • Table 382. Rest of Europe Competitive ELISA Sales, by Type Units (2025-2030)
  • Table 383. Rest of Europe Competitive ELISA Sales, by Application Units (2025-2030)
  • Table 384. Rest of Europe Competitive ELISA Sales, by ELISA Units (2025-2030)
  • Table 385. MEA Competitive ELISA Sales, by Country Units (2025-2030)
  • Table 386. MEA Competitive ELISA Sales, by Type Units (2025-2030)
  • Table 387. MEA Competitive ELISA Sales, by Application Units (2025-2030)
  • Table 388. MEA Competitive ELISA Sales, by ELISA Units (2025-2030)
  • Table 389. Middle East Competitive ELISA Sales, by Type Units (2025-2030)
  • Table 390. Middle East Competitive ELISA Sales, by Application Units (2025-2030)
  • Table 391. Middle East Competitive ELISA Sales, by ELISA Units (2025-2030)
  • Table 392. Africa Competitive ELISA Sales, by Type Units (2025-2030)
  • Table 393. Africa Competitive ELISA Sales, by Application Units (2025-2030)
  • Table 394. Africa Competitive ELISA Sales, by ELISA Units (2025-2030)
  • Table 395. North America Competitive ELISA Sales, by Country Units (2025-2030)
  • Table 396. North America Competitive ELISA Sales, by Type Units (2025-2030)
  • Table 397. North America Competitive ELISA Sales, by Application Units (2025-2030)
  • Table 398. North America Competitive ELISA Sales, by ELISA Units (2025-2030)
  • Table 399. United States Competitive ELISA Sales, by Type Units (2025-2030)
  • Table 400. United States Competitive ELISA Sales, by Application Units (2025-2030)
  • Table 401. United States Competitive ELISA Sales, by ELISA Units (2025-2030)
  • Table 402. Canada Competitive ELISA Sales, by Type Units (2025-2030)
  • Table 403. Canada Competitive ELISA Sales, by Application Units (2025-2030)
  • Table 404. Canada Competitive ELISA Sales, by ELISA Units (2025-2030)
  • Table 405. Mexico Competitive ELISA Sales, by Type Units (2025-2030)
  • Table 406. Mexico Competitive ELISA Sales, by Application Units (2025-2030)
  • Table 407. Mexico Competitive ELISA Sales, by ELISA Units (2025-2030)
  • Table 408. Competitive ELISA: by Type(USD/Units)
  • Table 409. Research Programs/Design for This Report
  • Table 410. Key Data Information from Secondary Sources
  • Table 411. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Competitive ELISA: by Type USD Million (2018-2023)
  • Figure 5. Global Competitive ELISA: by Application USD Million (2018-2023)
  • Figure 6. Global Competitive ELISA: by ELISA USD Million (2018-2023)
  • Figure 7. South America Competitive ELISA Share (%), by Country
  • Figure 8. Asia Pacific Competitive ELISA Share (%), by Country
  • Figure 9. Europe Competitive ELISA Share (%), by Country
  • Figure 10. MEA Competitive ELISA Share (%), by Country
  • Figure 11. North America Competitive ELISA Share (%), by Country
  • Figure 12. Global Competitive ELISA: by Type Units (2018-2023)
  • Figure 13. Global Competitive ELISA: by Application Units (2018-2023)
  • Figure 14. Global Competitive ELISA: by ELISA Units (2018-2023)
  • Figure 15. South America Competitive ELISA Share (%), by Country
  • Figure 16. Asia Pacific Competitive ELISA Share (%), by Country
  • Figure 17. Europe Competitive ELISA Share (%), by Country
  • Figure 18. MEA Competitive ELISA Share (%), by Country
  • Figure 19. North America Competitive ELISA Share (%), by Country
  • Figure 20. Global Competitive ELISA: by Type USD/Units (2018-2023)
  • Figure 21. Global Competitive ELISA share by Players 2023 (%)
  • Figure 22. Global Competitive ELISA share by Players (Top 3) 2023(%)
  • Figure 23. Global Competitive ELISA share by Players (Top 5) 2023(%)
  • Figure 24. BCG Matrix for key Companies
  • Figure 25. Bio-Rad Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 26. Bio-Rad Laboratories (United States) Revenue: by Geography 2023
  • Figure 27. Fisher Scientific (United States) Revenue, Net Income and Gross profit
  • Figure 28. Fisher Scientific (United States) Revenue: by Geography 2023
  • Figure 29. Cell Biolabs, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 30. Cell Biolabs, Inc. (United States) Revenue: by Geography 2023
  • Figure 31. Enzo Life Sciences, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 32. Enzo Life Sciences, Inc. (United States) Revenue: by Geography 2023
  • Figure 33. Sino Biological Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 34. Sino Biological Inc. (United States) Revenue: by Geography 2023
  • Figure 35. BioVision, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 36. BioVision, Inc. (United States) Revenue: by Geography 2023
  • Figure 37. Invitrogen (United States) Revenue, Net Income and Gross profit
  • Figure 38. Invitrogen (United States) Revenue: by Geography 2023
  • Figure 39. Hycult Biotech (Netherlands) Revenue, Net Income and Gross profit
  • Figure 40. Hycult Biotech (Netherlands) Revenue: by Geography 2023
  • Figure 41. Biomerieux (France) Revenue, Net Income and Gross profit
  • Figure 42. Biomerieux (France) Revenue: by Geography 2023
  • Figure 43. ALPCO (United States) Revenue, Net Income and Gross profit
  • Figure 44. ALPCO (United States) Revenue: by Geography 2023
  • Figure 45. Global Competitive ELISA: by Type USD Million (2025-2030)
  • Figure 46. Global Competitive ELISA: by Application USD Million (2025-2030)
  • Figure 47. Global Competitive ELISA: by ELISA USD Million (2025-2030)
  • Figure 48. South America Competitive ELISA Share (%), by Country
  • Figure 49. Asia Pacific Competitive ELISA Share (%), by Country
  • Figure 50. Europe Competitive ELISA Share (%), by Country
  • Figure 51. MEA Competitive ELISA Share (%), by Country
  • Figure 52. North America Competitive ELISA Share (%), by Country
  • Figure 53. Global Competitive ELISA: by Type Units (2025-2030)
  • Figure 54. Global Competitive ELISA: by Application Units (2025-2030)
  • Figure 55. Global Competitive ELISA: by ELISA Units (2025-2030)
  • Figure 56. South America Competitive ELISA Share (%), by Country
  • Figure 57. Asia Pacific Competitive ELISA Share (%), by Country
  • Figure 58. Europe Competitive ELISA Share (%), by Country
  • Figure 59. MEA Competitive ELISA Share (%), by Country
  • Figure 60. North America Competitive ELISA Share (%), by Country
  • Figure 61. Global Competitive ELISA: by Type USD/Units (2025-2030)
List of companies from research coverage that are profiled in the study
  • Bio-Rad Laboratories (United States)
  • Fisher Scientific (United States)
  • Cell Biolabs, Inc. (United States)
  • Enzo Life Sciences, Inc. (United States)
  • Sino Biological Inc. (United States)
  • BioVision, Inc. (United States)
  • Invitrogen (United States)
  • Hycult Biotech (Netherlands)
  • Biomerieux (France)
  • ALPCO (United States)
Additional players considered in the study are as follows:
BioLegend, Inc. (United States) , ZEUS Scientific, Inc. (United States) , Shenzhen YHLO Biotech Co., Ltd. (China) , Abnova (China)
Select User Access Type

Key Highlights of Report


Mar 2024 165 Pages 69 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Competitive ELISA Market research Quantitative research analysis
Global Competitive ELISA Market research Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Due to pricing constraints we only profile limited players in the study that includes a mix list of leaders and emerging players, however for evaluation of market size the coverage includes 100+ players.
Yes, the study does represent market size by key business segment, application/end users and major geographies forecasted till 2030
The Study can be customized to meet your requirements. Please connect with our representative, in case you wish to add or remove certain country or profiled players.
  • Lack of Awareness in Developing Countries

Know More About Global Competitive ELISA Market research Report?

Have a Query? Click Here

Other Related Reports

Medical Electrodes Comprehensive Study by Application (Cardiology, Neurophysiology, Electrosurgery, Intraoperative Monitoring (IOM), Sleep Study), Technology (Wet Electrodes, Dry Electrodes, Needle E...
$ 3750
Respiratory Inhaler Comprehensive Study by Type (Dry Powder Inhaler, Metered Dose Inhaler, Nebulizer), Application (Hospital and Clinic, Home Care), Distribution Channel (Supermarkets, Pharmacies, On...
$ 3500
Medical Kits and Trays Comprehensive Study by Type (Procedure-Specific Disposable Kits & Trays, Custom Procedure Kits & Trays, General-Use Kits & Trays, Benefits of Using Custom Trays, Home Test Kits...
$ 3350
Hospital Furniture Comprehensive Study by Type (Bedside Tables, Operating Table, Instrument Stands, Stretchers, Hospital Beds, Chairs, Scrub Sinks, Waste Container, Trolley, Others), Application (Phy...
$ 3650
Heart Lung Machine Comprehensive Study by Type (Single Roller Pump Heart Lung Machine, Double Roller Pump Heart Lung Machine), Application (Cardiac Surgery, Lung Transplant Operation, Acute Respirato...
$ 3350
MRI System Comprehensive Study by Application (Brain, Head and Neck, Spine, Musculoskeletal, Vascular, Pelvic and Abdomen, Breast, Cardiac, Others), Architecture (Closed MRI System, Open MRI System),...
$ 3450